Table 5.
CD percentages and cytokine level in IDU with HIV and HCV co-infection (mean ± SD)
Group | n | CD3 (%) | CD4 (%) | CD8 (%) | CD4/CD8 | IFN-γ (ng/L) | IL-4 (ng/L) |
Negative1 | 40 | 56.80 ± 4.42 | 41.9 ± 4.16 | 29.08 ± 2.85 | 1.44 ± 0.13 | 288.01 ± 40.03 | 20.76 ± 1.87 |
HCV infection | 45 | 58.23 ± 4.70 | 41.42 ± 3.65 | 29.33 ± 2.52 | 1.41 ± 0.12 | 282.86 ± 54.77 | 20.88 ± 1.42 |
HIV infection | 27 | 54.27 ± 4.23b | 39.49 ± 3.47a | 28.98 ± 3.11 | 1.36 ± 0.15b | 265.43 ± 38.71a | 20.23 ± 1.34 |
HIV+HCV-RNA- | 40 | 54.02 ± 3.66b | 39.29 ± 2.91b | 28.81 ± 2.42 | 1.36 ± 0.13b | 261.59 ± 43.68a | 20.46 ± 1.38 |
HIV+HCV-RNA+ | 25 | 53.82 ± 3.15b | 39.51 ± 2.91* | 28.58 ± 2.53 | 1.38 ± 0.13b | 263.57 ± 43.65a | 20.84 ± 1.56 |
P < 0.05,
P < 0.01 vs negative cases.
Viral infection markers were not discovered in IDU.